alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 88, Number 217 (Monday, November 13, 2023)]
[Notices]
[Page 77597]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24969]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Autoimmunity Centers of Excellence, 
Basic Research Program (U19 Clinical Trial Not Allowed).
    Date: December 6-8, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31, 
Rockville, MD 20892, (240) 669-5060, <a href="/cdn-cgi/l/email-protection#91fbf0fcf4e2bfe2ffe8f5f4e3d1fff8f9bff6fee7"><span class="__cf_email__" data-cfemail="ea808b878f99c49984938e8f98aa848382c48d859c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2023-24969 Filed 11-9-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
1-PH/1885859.1

DRAFT 09/22/03 10:31

UNITED STATES DISTRICT COURT FOR

THE EASTERN DISTRICT OF PENNSYLVANIA

____________________________________

Carol Stith, individually and on behalf :

of all others similarly situated, :

:

Plaintiff, :

: Civil Action No. 02-CV-4176

v. :

:

Merck & Co., Inc., :

:

Defendant. :

____________________________________:

WITHDRAW OF APPEARANCE

TO THE CLERK:

Kindly withdraw the appearance of Joshua R. Lubin on behalf of Defendant

Merck & Co., Inc. in the above-captioned action.

_________________________________________

Joshua R. Lubin (PA ID NO. 84431)

MORGAN, LEWIS & BOCKIUS LLP

1701 Market Street

Philadelphia, PA 19103

Attorney for Defendant

Dated: September 25, 2003

Case 2:02-cv-04176-CRW Document 13 Filed 09/29/2003 Page 1 of 2
1-PH/1885859.1

DRAFT 09/22/03 10:31

CERTIFICATE OF SERVICE

I, Joshua R. Lubin, hereby certify that on this 25th day of September,

2003, a true and correct copy of the foregoing Withdraw of Appearance has been served

via first class mail upon the following:

Robert T. Vance, Jr., Esquire

Suite 705

1616 Walnut Street

Philadelphia, PA 19103

And

Isaac H. Green, Jr., Esquire

Suite 700

1616 Walnut Street

Philadelphia, PA 19103

And

Joseph C. Kohn, Esquire

Martin J. D’Urso, Esquire

Kohn, Swift & Graf, P.C.

One South Broad Street, Suite 2100

Philadelphia, PA 19107

Attorneys for Plaintiff

______________________________

Joshua R. Lubin

Case 2:02-cv-04176-CRW Document 13 Filed 09/29/2003 Page 2 of 2
Electronic Other

"Electronic Other Original" refers to the submission of FAFSA data using the Electronic Data Exchange (EDE) process. With the FAFSA filer’s permission, a FAFSA can be submitted through a variety of software methods (e.g. a school’s third party servicer, a school’s mainframe computer, or a school’s proprietary software )

.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of RTG Ventures, Inc. (the
"Company") on Form 10-KSB for the year ended August 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Linda
Perry, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that;

            (1)   The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

            (2)   The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

         A signed original of this written statement required by Section 906 has
been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.

/s/ Linda Perry
----------------------------------
Name:  Linda Perry
Title: Chief Executive Officer
Date:  January 13, 2005
```

[Federal Register Volume 78, Number 243 (Wednesday, December 18, 2013)]
[Notices]
[Pages 76698-76699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30170]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 8553]

Waiver of Restriction on Assistance to the Central Government of 
Ethiopia

    Pursuant to Section 7031(b)(3) of the Department of State, Foreign 
Operations, and Related Programs Appropriations Act, 2012 (Div. I, Pub. 
L.

[[Page 76699]]

112-74) (``the Act''), as carried forward by the Further Continuing 
Appropriations Act, 2013 (Div. F, Pub. L. 113-6), and Department of 
State Delegation of Authority Number 245-1, I hereby determine that it 
is important to the national interest of the United States to waive the 
requirements of Section 7031(b)(1) of the Act and similar provisions of 
law in prior year Acts with respect to Ethiopia and I hereby waive this 
restriction.
    This determination and the accompanying Memorandum of Justification 
shall be reported to the Congress, and the determination shall be 
published in the Federal Register.

    Dated: July 10, 2013.
William J. Burns,
Deputy Secretary.
[FR Doc. 2013-30170 Filed 12-17-13; 8:45 am]
BILLING CODE 4710-26-P
```
No. 50865.

#### Petition 6504-R of Enrico A. Stein (New York).

Opinion by

Keefe, J.

At the trial it was established that in not following the prices advised by the appraiser and in transferring to the entry papers a sum not actually derived from a multiplication of the unit value and the net weight of the merchandise, petitioner’s broker had exhibited a lack of care in making the entry. However, it was held that there was nothing in the record tending to establish that there was an intention on his part to defraud the revenue of the United States or to conceal or to misrepresent the facts or to deceive the appraiser as to the value of the merchandise. *(Linen Thread Co.*v. *United States,*13 Ct. Cust. Appls. 395, T. D. 41322, cited.) The petition was therefore granted.
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

: CIVIL ACTION NOS.

:

TESSEL : 02-3865

FILIPPO : 02-3871

JONES, et al. : 02-3909

HOLMAN, et al. : 02-3918

LAMB : 02-3947

JONES : 02-3956

LARSON : 02-3981

DRENTLAW : 02-4142

DURHAM : 02-4160

SIEGEL, et al. : 02-4178

NELSON, et al. : 02-4202

FOSTER, et al. : 02-4222

SIMINUK, et al. : 02-4251

NITZKO, et al. : 02-4270

MICHALIK, et al. : 02-4888

:

:

VS. :

:

BAYER CORPORATION, et al. :

O R D E R

AND NOW, this day of July, 2002, the Court having been previously

advised that the above action cannot proceed to trial and disposition because of the following

reason:

[ ] - Order staying these proceedings pending disposition of a related

action.

[ ] - Order staying these proceedings pending determination of

arbitration proceedings.

[ ] - Interlocutory appeal filed.

[ X ] - Other: Case is placed into suspense pending receipt of the Case

Transfer Order from the Judicial Panel on Multi District Litigation

transferring case to District of Minnesota..

Case 2:02-cv-04160-PBT Document 2 Filed 07/12/2002 Page 1 of 2
It is

ORDERED that the Clerk of Court mark this action closed for statistical purposes and

place the matter in the Civil Suspense File, and it is

FURTHER ORDERED that the Court shall retain jurisdiction; and that the case be

restored to the trial docket when the action is in a status so that it may proceed to final

disposition; this order shall not prejudice the rights of the parties to this litigation.

BY THE COURT:

________________________________________

Petrese B. Tucker, Judge

Case 2:02-cv-04160-PBT Document 2 Filed 07/12/2002 Page 2 of 2
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

KESTER SANDY : CIVIL ACTION NO. 20-3290

:

v. : CRIMINAL NO. 04-324

:

UNITED STATES OF AMERICA :

ORDER

NOW, this 10th day of March, 2021, upon consideration of the Petition for Writ of 

Habeas Corpus Under 28 U.S.C. § 2241 (Doc. No. 1), it is ORDERED that the petition is 

DISMISSED WITHOUT PREJUDICE.

/s/ TIMOTHY J. SAVAGE J.

Case 2:04-cr-00324-TJS Document 54 Filed 03/10/21 Page 1 of 1
1

 Parties include all persons, corporations or other business entities, and insurance companies with

an interest in the case, and each entity with an interest in the case must attend the conference. In the case of

corporate or other business entities, the corporate official with ultimate settlement authority is required to attend. 

Where an insurance company is involved, a representative with ultimate settlement authority is also required to

attend. 

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

MARTIN : CIVIL ACTION

:

v. :

:

L.F. LAMBERT SPAWN CO., INC. : NO.02-2754

:

:

ORDER

A Settlement Conference in the above-captioned case will be held on APRIL 14,

2003 at 10:00am before the Honorable Linda K. Caracappa, United States Magistrate Judge, in

Room 3042, U.S. Courthouse, 601 Market Street, Philadelphia, PA 19106.

The Court assumes that settlement of this case is a real possibility, and the Court

has set aside the entire day for this conference. Parties are to remain present until expressly

released by the Court.

Counsel are directed to have clients with ultimate authority to settle

physically PRESENT in the courtroom for the duration of this conference.

1

 

Counsel are further directed to complete the enclosed Settlement Conference

Summary to be faxed or mailed to Chambers on or before April 7, 2003.

BY THE COURT:

 

Hon. Linda K. Caracappa

267-299-7640/267-299-5075 Fax

Date: March 12, 2003

cc: 

Case 2:02-cv-02754-MAM Document 10 Filed 03/12/2003 Page 1 of 1
Order entered February 22, 2017

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05 - 16 - 01481 - CV IN RE BCH DEVELOPMEN T, LLC, Relator Original Proceeding from the County Court at Law No . 1

Dallas County, Texas Trial Court Cause No. CC - 13 - 05900 - A



### O RDER Before the Court is relator’s December 16, 2016 petition for writ of mandamus
. The Court requests that the r eal p art ies in i nterest and r espondent file their responses to the petition, i f
an y, on or before March 8, 2017
. /s/ DAVID J. SCHENCK JUSTICE
EXHIBIT 13.2



Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the Annual Report for Fiscal 2008 Ended August 31, 2008 of Golden Goliath Resources Ltd., company organized under the British Columbia Corporations Act(the Company) on Form 20-F as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Stephen Pearce, Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S) 906 of the Sarbanes-Oxley Act of 2002, that:



(1)  The Report fully complies with the requirements of section 13(a) or

15(d) of the Securities Exchange Act of 1934; and



(2)  The information contained in the Report fairly presents, in all

material respects, the financial condition and result of operations

of the Company.



/s/ Stephen Pearce

Stephen Pearce, Chief Financial Officer





Date: February 27, 2009





#
EXHIBIT 32.1

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of J.Crew Group, Inc. (the Company) on Form 10-Q for the period ended November 1, 2008
as filed with the Securities and Exchange Commission on the date hereof (the Report), we, Millard S. Drexler, Chief Executive Officer of the Company, and James S. Scully, Chief Administrative Officer and Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of each of our knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: December 10, 2008



|                                                        
|--------------------------------------------------------
|/s/    MILLARD S. DREXLER                               
|Millard S. Drexler                                      
|Chief Executive Officer                                 
|                                                        
|/s/    JAMES S. SCULLY                                  
|James S. Scully                                         
|Chief Administrative Officer and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
# C_2016059EN.01004901.xml

| 15.2.2016 | EN | Official Journal of the European Union | C 59/49 |
| --- | --- | --- | --- |

15.2.2016

EN

Official Journal of the European Union

C 59/49

---

Action brought on 21 December 2015 — Tengelmann Warenhandelsgesellschaft v OHIM — Fédération Internationale des Logis (T)

(Case T-756/15)

(2016/C 059/56)

Language in which the application was lodged: English

Parties

Parties

Applicant: Tengelmann Warenhandelsgesellschaft KG (Mülheim an der Ruhr, Germany) (represented by: H. Prange, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Defendant:

Other party to the proceedings before the Board of Appeal: Federation Internationale des Logis (Paris, France)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before OHIM

Details of the proceedings before OHIM

Applicant of the trade mark at issue: Applicant

Applicant of the trade mark at issue:

Trade mark at issue: Community word mark ‘T’ — Application for registration No 11 623 022

Trade mark at issue:

Procedure before OHIM: Opposition proceedings

Procedure before OHIM

Contested decision: Decision of the Fifth Board of Appeal of OHIM of 31 August 2015 in Case R 2653/2014-5

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | set aside the contested decision, and amend it to the effect that the opposition is rejected in its entirety; |
| --- | --- |

—

set aside the contested decision, and amend it to the effect that the opposition is rejected in its entirety;

| — | order of the defendant and, as the case may be, the other party to the proceedings before the Board of Appeal to pay the costs of the proceedings, including the costs of the appeal proceedings. |
| --- | --- |

—

order of the defendant and, as the case may be, the other party to the proceedings before the Board of Appeal to pay the costs of the proceedings, including the costs of the appeal proceedings.

Plea in law

Plea in law

| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation No 207/2009.

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          17,359
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 3,230
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    233,923
<INVESTMENTS-CARRYING>                          69,694
<INVESTMENTS-MARKET>                            68,557
<LOANS>                                        729,266
<ALLOWANCE>                                   (11,269)
<TOTAL-ASSETS>                               1,097,160
<DEPOSITS>                                     664,690
<SHORT-TERM>                                   112,000
<LIABILITIES-OTHER>                             10,354
<LONG-TERM>                                    218,225
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            53
<OTHER-SE>                                      91,838
<TOTAL-LIABILITIES-AND-EQUITY>               1,097,160
<INTEREST-LOAN>                                 39,190
<INTEREST-INVEST>                               14,788
<INTEREST-OTHER>                                   894
<INTEREST-TOTAL>                                54,872
<INTEREST-DEPOSIT>                              16,319
<INTEREST-EXPENSE>                              27,827
<INTEREST-INCOME-NET>                           27,045
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   5
<EXPENSE-OTHER>                                 17,716
<INCOME-PRETAX>                                 17,408
<INCOME-PRE-EXTRAORDINARY>                      11,539
<EXTRAORDINARY>                                  (435)
<CHANGES>                                            0
<NET-INCOME>                                    11,104
<EPS-BASIC>                                       2.21
<EPS-DILUTED>                                     2.13
<YIELD-ACTUAL>                                    7.19
<LOANS-NON>                                      1,981
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                   667
<LOANS-PROBLEM>                                 13,885
<ALLOWANCE-OPEN>                                12,301
<CHARGE-OFFS>                                    1,612
<RECOVERIES>                                       580
<ALLOWANCE-CLOSE>                               11,269
<ALLOWANCE-DOMESTIC>                             6,014
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                          5,255


</TABLE>
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 1 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 2 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 3 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 4 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 5 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 6 of 7
Case 2:03-cv-06604-JP Document 514 Filed 06/29/12 Page 7 of 7
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 76836)    
                    Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel RFA-OD-23-013 and RFA-OD-23-014—Understanding Chronic Conditions Understudied Among Women Special Emphasis Panel (SEP), November 20, 2023, 10:00 a.m. to November 21, 2023, 06:30 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the                     **Federal Register**                     on October 27, 2023, 88 FR 73865 Doc 2023-23748                

This meeting is being amended to change the Panel name to Center for Scientific Review Special Emphasis Panel RFA-OD-23-013 and RFA-OD-23-014—Understanding Chronic Conditions Understudied Among Women. The meeting is closed to the public.

Dated: November 2, 2023.

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-24579 Filed 11-6-23; 8:45 am]

BILLING CODE 4140-01-P